Search
Anecortave acetate
go.drugbank.com/drugs/DB05288InvestigationalAnecortave acetate (Retaane) is an analog of cortisol acetate; among the modifications to the steroid are the removal of the 11ß hydroxyl OH group and an addition of a 21-acetate group.
Loracarbef
go.drugbank.com/drugs/DB00447ApprovedWithdrawnLoracarbef is a carbacephem antibiotic sometimes grouped together with the second-generation cephalosporin antibiotics. It is marketed under the trade name Lorabid.
Neocartilage
go.drugbank.com/drugs/DB05257InvestigationalNeocartilage is the only scaffold-free living cartilage graft on the market.
Poloxalene
go.drugbank.com/drugs/DB11451InvestigationalVet approvedEthylene oxide/propylene oxide copolymer is used as a food additive. It belongs to the family of Epoxides. These are compounds containing a cyclic ether with three ring atoms (one oxygen and two carbon atoms).
Categories: Compounds used in a research, industrial, or household setting2,3-Dimercapto-1-propanesulfonic acid
go.drugbank.com/drugs/DB15967InvestigationalCategories: Compounds used in a research, industrial, or household settingt-Butylhydroquinone
go.drugbank.com/drugs/DB07726ExperimentalCategories: Compounds used in a research, industrial, or household settingD-Tryptophan
go.drugbank.com/drugs/DB03225ExperimentalTryptophan is one of the 20 standard amino acids, as well as an essential amino acid in the human diet. It is encoded in the standard genetic code as the codon UGG. … The distinguishing structural characteristic of tryptophan is that it contains an indole functional group. It is an essential amino acid as defined by its growth effects on rats.
Epratuzumab
go.drugbank.com/drugs/DB04958InvestigationalThis agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.
Toloxatone
go.drugbank.com/drugs/DB09245ExperimentalToloxatone is an antidepressant agent, the first ever use of which was in France, 1984. It acts as a selective and reversible inhibitor of monoamine oxidase-A (MOA) [L1388].
Pozelimab
go.drugbank.com/drugs/DB15218ApprovedInvestigational[A261115] The loss of CD55 can therefore induce complement hyperactivation, causing the unwanted formation of membrane-attacking complex and resulting in paroxysmal nocturnal hemoglobinuria and complement-mediated … autoimmune hemolysis that are often observed in CHAPLE disease.